Search
-
Truth & Trust: Insights for Your Brand
Hear why focusing merely on brand purpose is no longer relevant for consumers, and that the roles of corporates and brands are evolving in the eyes of consumers.
-
Two in five Americans likely to travel this holiday season
New Ipsos Poll finds that one in ten have already planned/booked a trip that involves an overnight stay this holiday season
-
The Election Is Over: What’s Next?
From the beginning, Joe Biden was favored. But President Trump enjoyed structural advantages based on Ipsos' analysis of hundreds of past election results.
-
Drop in optimism among Republicans drives down U.S. consumer sentiment slightly amid vote count
Confidence index in days after election down 1.2 points from the previous week
-
[RECORDING] World Happiness Academy: Unlocking the Power of Belonging
Join Ipsos and thousands more for a summit focused on feeling, understanding and acting on the drivers to evolve and expand individuals and societies that thrive.
-
[WEBINAR] Are we ready to get back to sharing again?
Don’t miss hearing Ipsos' John Kiser, SVP of Automotive & Mobility, and Mike VanNieuwkuyk, SVP of Automotive Advisory delve into the impact that Covid-19 is having on Shared Mobility preferences among American consumers relative to the world.
-
Nearly 9 in 10 Americans want all votes counted no matter who wins
New Reuters/Ipsos poll shows most do not believe Trump’s victory declaration is justified; majority believe local election officials are doing their jobs honestly
-
[WEBINAR] Media in this Brave (New) World: Vaccine or Not
Join Ipsos for a complimentary virtual panel discussion exploring pandemic research and what that means for a post-vaccine, post-election, post-anything world.
-
COVID-19 vaccination intent is decreasing globally
Most adults across 15 countries don’t expect a vaccine to be available any sooner than mid-2021; only half would get vaccinated within three months of its availability.
-
US NEXT Innovation
Join Ipsos at NEXT Innovation Week USA – a virtual conference spanning 5 days, 10 sessions, 40 speakers and selective content about pharma commercial and medical future.